117140-77-9 Usage
General Description
Indole-2,5-dicarboxylic acid is an organic compound, identified as a dicarboxylic acid where carbon atoms 2 and 5 of an indole ring system are substituted with carboxy groups. It is typically colorless to light yellow and falls under the aromatic heteropolycyclic compounds class. This chemical can be classified as a member of the indoles or indolecarboxylic acids and derivatives. It can be prepared through a synthesis process involving several steps, such as dehydration and oxidation. Furthermore, it plays a significant role in various industries owing to its potential applications, including use in material chemistry for semiconductor and pharmaceutical industries. The compound is often used in research due to its valuable properties.
Check Digit Verification of cas no
The CAS Registry Mumber 117140-77-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,1,4 and 0 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 117140-77:
(8*1)+(7*1)+(6*7)+(5*1)+(4*4)+(3*0)+(2*7)+(1*7)=99
99 % 10 = 9
So 117140-77-9 is a valid CAS Registry Number.
117140-77-9Relevant articles and documents
Investigations of SCIO-469-like compounds for the inhibition of p38 MAP kinase
Laufer, Stefan,Lehmann, Frank
supporting information; body text, p. 1461 - 1464 (2009/11/30)
The p38 MAP kinase is implicated in the release of the pro-inflammatory cytokines TNFα and IL-1b. Inhibition of cytokine release may be a useful treatment for inflammatory conditions such as rheumatoid arthritis and Crohn's disease. A new lead structure for p38 MAP kinase inhibition was identified. Herein, we report the SAR of this new class of p38 inhibitors.
Novel compounds possessing antibacterial, antifungal or antitumor activity
-
, (2008/06/13)
The present invention provides novel compounds possessing one or more of the following activities: antibacterial, antifungal and antitumor activity. The compounds are of Formula (I): Pharmaceutical compositions containing these compounds, methods of making and methods for using these compounds are also provided.